UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 309

Sortiert nach

Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study

Therapeutic apheresis and dialysis, 2020-04, Vol.24 (2), p.115-125

2020

Link zum Volltext

Verfügbarkeit prüfen

Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients

Therapeutic apheresis and dialysis, 2021-10, Vol.25 (5), p.575-585

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies

Advances in therapy, 2021-10, Vol.38 (10), p.5345-5360

2021

Link zum Volltext

Verfügbarkeit prüfen

Spatial analysis of p63, K5 and K7 defines two groups of progenitor cells that differentially contribute to the maintenance of normal sebaceous glands, extraocular sebaceous carcinoma and benign sebaceous tumors

Journal of dermatology, 2019-03, Vol.46 (3), p.249-258

2019

Link zum Volltext

Verfügbarkeit prüfen

Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease

Journal of clinical medicine, 2023-06, Vol.12 (13), p.4217

2023

Link zum Volltext

Verfügbarkeit prüfen

Umbruch und Aufbruch Laudatio zum 80. Geburtstag von Dr. Erich Schubert

Journal der Deutschen Dermatologischen Gesellschaft, 2019-10, Vol.17 (10), p.1105-1107

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan

Journal of the American Society of Nephrology, 2020-07, Vol.31 (7), p.1628-1639

2020

Link zum Volltext

Verfügbarkeit prüfen

Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation Study

Acta dermato-venereologica, 2019-02, Vol.99 (2), p.211-217

2019

Link zum Volltext

Verfügbarkeit prüfen

patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases

Archives of Dermatological Research, 2009-09, Vol.301 (8), p.561-571

2009

Link zum Volltext

Verfügbarkeit prüfen

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Journal der Deutschen Dermatologischen Gesellschaft, 2019-10, Vol.17 (10), p.1105-1107

2019

Link zum Volltext

Verfügbarkeit prüfen

Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)

Nephrology, dialysis, transplantation, 2021-08, Vol.36 (9), p.1616-1628

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis

Nephron (2015), 2020-08, Vol.144 (8), p.372-382

2020

Link zum Volltext

Verfügbarkeit prüfen

Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

Advances in therapy, 2019-06, Vol.36 (6), p.1438-1454

2019

Link zum Volltext

Verfügbarkeit prüfen

Oral roxadustat three times weekly in ESA‐naïve and ESA‐converted patients with anemia of chronic kidney disease on hemodialysis: Results from two phase 3 studies

Therapeutic apheresis and dialysis, 2020-12, Vol.24 (6), p.628-641

2020

Link zum Volltext

Verfügbarkeit prüfen

Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)

Nephrology, dialysis, transplantation, 2021-08, Vol.36 (9), p.1629-1639

2021

Link zum Volltext

Verfügbarkeit prüfen

Umbruch und Aufbruch Laudatio zum 80. Geburtstag von Dr. Erich Schubert

Journal der Deutschen Dermatologischen Gesellschaft, 2019-10, Vol.17 (10), p.1105-1107

2019

Link zum Volltext

Verfügbarkeit prüfen

Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES)

Advances in therapy, 2021-10, Vol.38 (10), p.5361-5380

2021

Link zum Volltext

Verfügbarkeit prüfen

Manipulated Evidence?

Deutsches Ärzteblatt international, 2014-01

2014

Link zum Volltext

Verfügbarkeit prüfen

Authors’ Reply

Journal of the American Society of Nephrology, 2021-04, Vol.32 (4), p.1005-1007

2021

Link zum Volltext

Verfügbarkeit prüfen

Authors’ Reply

Journal of the American Society of Nephrology, 2021-03, Vol.32 (4), p.1005-1007

2021

Link zum Volltext

Verfügbarkeit prüfen

Authors’ Reply

Journal of the American Society of Nephrology, 2020-11, Vol.31 (11), p.2738-2740

2020

Link zum Volltext

Verfügbarkeit prüfen

A Phase 3, Multicenter, Randomized, Open-Label, Active Comparator Conversion Study of Roxadustat in Non-Dialysis-Dependent (NDD) Patients with Anemia in CKD: PO0269

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.134-134

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD

Kidney international reports, 2021-07, Vol.6 (7), p.1810-1828

2021

Link zum Volltext

Verfügbarkeit prüfen

Authors’ Reply

Journal of the American Society of Nephrology, 2020-09, Vol.31 (11), p.2738-2740

2020

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES)

Nephrology, dialysis, transplantation, 2022-03, Vol.37 (4), p.805-805

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 309

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(295)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(287)
Japanisch
(33)
Deutsch
(29)
Croatian
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study

Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients

Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies

Spatial analysis of p63, K5 and K7 defines two groups of progenitor cells that differentially contribute to the maintenance of normal sebaceous glands, extraocular sebaceous carcinoma and benign sebaceous tumors

Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease

Umbruch und Aufbruch Laudatio zum 80. Geburtstag von Dr. Erich Schubert

Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan

Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation Study

patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)

A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis

Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

Oral roxadustat three times weekly in ESA‐naïve and ESA‐converted patients with anemia of chronic kidney disease on hemodialysis: Results from two phase 3 studies

Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)

Umbruch und Aufbruch Laudatio zum 80. Geburtstag von Dr. Erich Schubert

Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES)

Manipulated Evidence?

Authors’ Reply

Authors’ Reply

Authors’ Reply

A Phase 3, Multicenter, Randomized, Open-Label, Active Comparator Conversion Study of Roxadustat in Non-Dialysis-Dependent (NDD) Patients with Anemia in CKD: PO0269

Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD

Authors’ Reply

Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES)

Suchergebnisse filtern